Intellia Therapeutics, Inc. (NTLA): 10-Q filed Nov 5, 2026

Form type

10-Q

Filing date

Nov 5, 2026

Accession number

0001193125-26-449862

Filer

Intellia Therapeutics, Inc. (CIK 1652130)